<html>
<head>PUBMED IDs for MIRK</head>
<body bgcolor='#C5F0F2'><h1>MIRK</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15611642/'>HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathways.</a> December 22  2004<br></body></html>
